Dhaka, Bangladesh
Banglsdesh daily corona deaths lowest at 14

Banglsdesh daily corona deaths lowest at 14

Cases little rise to 5.66pc from 5pc

News Report: Bangladesh has registered 14 new fatalities from the coronavirus, the lowest daily count in two months, and 890 fresh cases in continuation of rather low incidence of the pandemic in the country for most of the winter days. The latest count took the death toll to 7,833 and the tally of infections to 524,910 after 890 people tested positive for the COVID-19 in the 24 hours to 8 am Wednesday, according to data released by the health department. Another 841 patients recovered from the illness through treatment at home and in hospital care in the same period, bringing the total to 469,522. A total of 15,727 samples were tested at 199 authorised labs across the country in the last 24 hours, yielding a positivity rate of 5.66 percent, also among the lowest rates. The latest official figures put the recovery rate at 89.45 percent while the mortality rate stands at 1.49 percent. Globally, over 91.65 million people have been infected with the novel coronavirus and 1.96 million have died, according to a tally by Johns Hopkins University. Infections have been reported in more than 210 countries and territories since the first cases were identified in China in December 2019. The country may improve in the days to come, despite worrying spikes in some developed countries, following vaccine breakthroughs and emerging warmer weather conditions. Meanwhile, the first shipment of Oxford AstraZeneca vaccine is likely to reach Bangladesh between January 21 and 25 for vaccination against the coronavirus pandemic. Officials of the Directorate General of Health Services said this at a press briefing on Monday afternoon. DGHS will get the vaccines from importing company Pharmaceuticals on January 27. "The government is going to launch online registration for Covid-19 vaccine recipients from January 26," the DGHS said. Vaccination may start countrywide on February 27. Bangladesh will get the Oxford-AstraZeneca vaccine from Serum Institute of India under a deal. The government has purchased three crore shots of the vaccine from Serum for $4 per shot, according to the tripartite agreement signed between it, SII and Beximco Pharmaceuticals on November 5 last year. In a landmark potential invention in medication a Bangladesh institution is poised to do final trials of a nasal spray that can kill the virus for both preventive and curative treatments.

Share |